Written Question·Department for Science, Innovation and Technology·UIN 901341
Drugs: Safety
Tabled: 14 November 2024
Answered: 20 November 2024
Named DayQuestion
Ben Obese-Jecty
Conservative — Huntingdon
What discussions he has had with the Medicines and Healthcare products Regulatory Agency on how to accelerate the acceptance of data generated in non-animal methods for drug safety decision making.
Answer
Feryal ClarkThe Medicines and Healthcare products Regulatory Agency (MHRA) attended a ministerial roundtable on accelerating the adoption of alternatives to using animals for drug development earlier this year.